AstraZeneca said on Monday that the company plans to apply for emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine in the first half of April. ...
There is no signal of concern regarding the use of Oxford-AstraZeneca COVID-19 vaccine in the country, said Dr VK Paul, Member (Health) of the Niti Aayog, on Wednesday amid speculations and subsequent review of possible side-effects of the vaccine. ...
After several European countries suspended the use of the Oxford-AstraZeneca COVID-19 vaccine over blood clot concerns, the European Medicines Agency (EMA) on Tuesday (local time) said regulators remain confident in the safety of the vaccine. ...